MedPath

Endoscopic Resection of Bladder Tumors

Not Applicable
Completed
Conditions
Bladder Tumor
Registration Number
NCT01750970
Lead Sponsor
Hopital Foch
Brief Summary

To confirm the benefit of endoscopic resection under fluorescence and blue light of high grade non-muscle invasive bladder tumor, and verifying if the second endoscopic resection recommended nowadays can be deleted.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • 18 year-old and older male and female subjects having high grade non-muscle invasive bladder tumor, with urinary cytology , imaging examination (Ultrasound, urography, or scan) and endoscopic examination
Exclusion Criteria
  • Less than 18 years of age, and having no:
  • Non-muscle invasive tumor, and of low grade.
  • Bladder tumor infiltrating the muscular layer shown by pre-operative test, with absence of urinary cytology
  • No blue light source in sustainable way

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of extra lesions revealed by blue light compared to the resection performed in white light2 to 6 weeks after resection
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital FOCH

🇫🇷

Suresnes, France

Hôpital FOCH
🇫🇷Suresnes, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.